Fax: (011) 33 1 42 49 95 65.
Original Article
VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma
Article first published online: 26 NOV 2007
DOI: 10.1002/cncr.23186
Copyright © 2007 American Cancer Society
Additional Information
How to Cite
Rivet, J., Mourah, S., Murata, H., Mounier, N., Pisonero, H., Mongiat-Artus, P., Teillac, P., Calvo, F., Janin, A. and Dosquet, C. (2008), VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma. Cancer, 112: 433–442. doi: 10.1002/cncr.23186
Publication History
- Issue published online: 4 JAN 2008
- Article first published online: 26 NOV 2007
- Manuscript Accepted: 9 AUG 2007
- Manuscript Revised: 3 AUG 2007
- Manuscript Received: 23 APR 2007
Funded by
- University Paris 7
- Inserm
- GIP/HMR
- PHRC
- Abstract
- Article
- References
- Cited By
Keywords:
- laser microdissection;
- renal cell carcinoma;
- VEGF;
- VEGFR-1;
- VEGFR-2
Abstract
BACKGROUND.
Tumor angiogenesis is a dynamic process that plays a major role in cancer progression. Vascular endothelial growth factor (VEGF) and its receptors play a pivotal role in angiogenesis. The expression of VEGF and its receptors VEGFR-1 and VEGFR-2 in renal cell carcinoma (RCC) was investigated in the perspective of anti-VEGF treatments.
METHODS.
Total VEGF protein levels were quantified by enzyme-linked immunosorbent assay (ELISA) in tumor tissue samples from surgical specimens of 65 patients with clear cell RCC. At the cellular level the VEGF isoforms VEGFR-1 and VEGFR-2 mRNA were quantified by real-time quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) in laser-microdissected tumoral epithelial as stromal cells and in corresponding normal tissue compartments. Colocalization of VEGF and VEGFR-1 proteins was studied by triple immunofluorescent labeling.
RESULTS.
Protein VEGF in cytosolic extracts was significantly higher in tumoral than in nontumoral tissue (P < .0001). Event-free survival was significantly longer for patients with cytosolic VEGF lower than the cutoff (75th percentile of VEGF protein levels, P = .02). In laser-microdissected epithelial cells, VEGF121 and VEGFR-1 mRNA expressions were higher in RCC than in corresponding nontumoral kidney (P = .007 and P = .002, respectively); they were also higher in stromal cells of RCC compared with nontumoral kidney (P = .02 and P = .003, respectively). There was no differential VEGFR-2 expression in epithelial or in stromal cells of tumoral or nontumoral kidney. By immunofluorescent labeling VEGF and VEGFR-1 colocalized on RCC tumor epithelial and stromal cells.
CONCLUSIONS.
Combined laser microdissection and quantitative RT-PCR, as triple immunofluorescent labeling, underlined the preferential expression of the most soluble VEGF isoform, VEGF121, and its receptor VEGFR-1, but not VEGFR-2, in epithelial and stromal cells of RCC. Cancer 2008. © 2007 American Cancer Society.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)